RTP drugmaker secures up to $45M despite regulatory speed bumps

A Triangle drugmaker has the capital to support its commercialization process. But it's faced challenges earning drug approval from the FDA.

Source: bizjournals.com Health Care:Physician Practices headlines - August 2, 2022 Category: American Health Authors: Zac Ezzone Source Type: news